Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5463_Библиотеки_им_академика_М_И_Перельмана.pdf
168
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
KEYWORDS
• graphene
• graphene oxide
• reduced graphene oxide
• graphene quantum dots
• biomedical applications
• tissue engineering
REFERENCES
Synth. Met. 2015, 200, 54–57.
Int. J. Biol. Macromol.
2017, 98, 287–291.
Appl. Surf. Sci. 1993, 70, 163–168.
Mater. Today 2012,
15 (3), 86–97.
Bioconjugate. Chem. 2018, 29 (2), 528–537.
ACS Nano. 2008,
2 (3), 463–470.
Brodie, B. Sur Le Poidsatomique Du Graphite. Ann Chim Phys. 1860, 59, E472.
Acid and Chlorogenic Acid. Pharm. Res. 2019, 36, 1–11.
Nature
2013, 500 (7463), 486–489.
ACS Sustain. Chem. Eng.
2018, 6 (3), 3862–3869.
Graphene-based System for Drug Delivery and Biomedical Application
169
Langmuir 2016, 32 (11), 2731–2736.
Lasers Med. Sci. 2016, 31, 1123–1131.
Nat. Mater. 2009, 8 (3), 203–207.
J. Phys. Chem. C 2010, 114 (14), 6426–6432.
ACS Biomater. Sci. Eng. 2018, 4 (8), 2653–2703.
Flatchem 2021, 30, 100315.
Int. J. Nanomed. 2020, 5991–6006.
Adv.
Healthcare Mater. 2013, 2 (11), 1489–1500.
J. Mat. Chem.
B 2015, 3 (27), 5588–5594.
J. Biomed. Mater. Res. A 2012, 100 (1),
141–148.
J. Am. Chem. Soc. 1958,
80 (6), 1339–1339.
Polyethylenimine Nanocomposite. Small 2014, 10 (1), 117–126.
Single Layer Graphite Structures Produced on Pt (111) by Hydrocarbon Decomposition.
Surf. Sci. 1992, 264 (3), 261–270.
ACS
Nano 2011, 5 (9), 7334–7341.
Nat. Nanotechnol. 2008, 3 (2), 101–105.
ACS Appl. Nano Mater. 2022, 5
(5), 6890–6900.
ACS Appl. Mater. Interfaces, 2016, 8 (45), 31311–31320.
170
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Science 2009, 324 (5932), 1312–1314.
Photovoltaics. Adv. Mater. 2011, 23 (6), 776–780.
Nano Lett. 2013, 13 (9), 4075–4079.
P. 2010,Science 327 (5966),
662–662.
Nanomedicine 2012, 7 (12), 1801–1812.
Imaging and Drug Delivery. J. Mater. Chem. 2011, 21 (32), 12034–12040.
Delivery Vectors. ACS Appl. Mater. Interfaces 2014, 6 (11), 8173–8183.
Quantum Dots. Nat. Nanotechnol. 2011, 6 (4), 247–252.
Int. J. Nanomed. 2012,
1737–1747.
ACS Appl. Mater. Interfaces 2022, 14 (49),
54431–54438.
J. Colloid Interface Sci. 2017, 490, 598–607.
ACS Nano 2010, 4 (8),
4806–4814.
J. Drug Targeting 2015, 23
(7–8), 605–618.
Surf. Sci. 1969, 17 (1), 267–270.
ACS Nano
2015, 9 (3), 2711–2719.
ACS Appl. Mater. Interfaces
2016, 8 (21),
13282–13293.
Graphene-based System for Drug Delivery and Biomedical Application
171
ACS Appl. Mater. Interfaces 2014, 6 (18), 16395–16402.
RSC Advances
2017, 7 (34), 20779–20788.
Nanosc. Horizons 2019, 4 (2), 273–290.
Blue-Luminescent Graphene Quantum Dots. Adv. Mater. 2010, 22 (6), 734–738.
ACS Nano 2013, 7 (9),
8147–8157.
Small 2015, 11
(27), 3358–3368.
ACS Appl. Mater. Interfaces 2023.
Nano Lett. 2009, 9 (1), 30–35.
RSC Adv . 2015, 5 (62), 50196–50211.
Nanoscale 2011, 3 (6), 2461–2464.
Small 2012, 8 (8), 1251–1263.
A Green Chemistry Approach. Mater. Lett. 2015, 161, 476–479.
Nanoscale 2014, 6 (11), 5799–5806.
Chem. Commun. 2011, 47 (9), 2580–2582.
Adv. Funct. Mater. 2009, 19 (12),
1987–1992.
ACS Nano 2011,
5 (6), 4987–4996.
172
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
and pH-Responsive Anticancer Drug Delivery. ACS Appl. Mater. Interfaces 2014, 6 (15),
11882–11890.
Eur. J. Inorg. Chem. 1899, 32,
1394–1399.
ACS Biomater. Sci. Eng. 2016, 2 (8),
1357–1366.
Nano Res. 2008, 1, 203–212.
ACS Biomater. Sci. Eng. 2020, 6 (7), 4214–4224.
Photoacoustic Imaging. ACS Appl. Mater. Interfaces 2016, 8 (25), 16465–16475.
J. Colloid Interface
Sci. 2018, 516, 332–341.
Graphene Oxide, Nanoscale Res. Lett. 2010, 6 (1), 8.
J. Mater. Chem. B 2018, 6 (5), 707–717.
ACS Appl. Mater. Interfaces 2017, 9 (34),
29055–29062.
Graphene Oxide Nanosheets. RSC Adv . 2014, 4 (104), 60102–60105.
Graphene. ACS Appl. Mater. Interfaces 2014, 6 (23), 21615–21623.
ACS Nano 2013, 7 (2), 1281–1290.
ACS Appl. Mater. Interfaces 2017, 9 (6), 5382–5391.
ACS Nano
2016, 10 (3), 3267–3281.
Graphene Oxide as a Nanocarrier. ACS Appl. Mater. Interfaces 2015,
7 (2), 1355–1363.
Graphene-based System for Drug Delivery and Biomedical Application
173
Magnetic Nanoparticles. Adv. Mater. 2012, 24 (14), 1868–1872.
ACS Nano 2011, 5
(1), 516–522.
Nano Lett. 2010, 10 (9),
3318–3323.
Cytoplasm-Selective Rapid Drug Delivery. Adv. Funct. Mater. 2017, 27 (14), 1604620.
Adv. Funct. Mater. 2014, 24 (41), 6455–6464.
Biomaterials 2012, 33 (16), 4013–4021.
Metastasis. Mater. Sci. Eng. C 2017, 79, 185–190.
and pH Value. Talanta 2016, 150, 54–60.
J. Mater. Chem. 2012, 22 (15),
7461–7467.
Nano Today 2017, 16, 82–96.
Chem. Commun. 2008, 41, 5116–5118.
RSC Adv. 2014, 4 (46),
24232–24239.
ACS
Appl. Mater. Interfaces 2018, 10 (7), 6608–6617.
Theranostics 2018, 8 (12), 3317.
ACS Nano 2019, 13 (8), 9595–9606.
174
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Chem. Commun. 2011, 47 (24), 6858–6860.
Advances in Pharmaceutical T echnology for Drug Delivery Systems (PTDDS), Volume 2: Recent Progress
in Biomedical Applications. Sougata Jana (Ed.)
© 2025 Apple Academic Press, Inc. Co-published with CRC Press (Taylor & Francis)
Nanotechnology in Gene Delivery
B. S. DHANYA
1
, and M. CHAMUNDEESWARI
2
1
Tamil Nadu, India
2
Chennai, India
CHAPTER 6
ABSTRACT
carbon nanotubes, liposomes, protein- and peptide-based nanoparticles, and
nanoscale polymeric materials can be used to develop these nonviral vectors.
biological systems.
6.1 INTRODUCTION
-
176
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
-
gene delivery vectors that use genetic components such as DNA plasmids,
-
-
tions such as cancer, AIDS, and cardiovascular disorders, gene delivery
on the employing nanosystem (Hamimed et al., 2022). It appears that
gene therapy is crucial because in vivo gene delivery is thought to be
Nanotechnology in Gene Delivery
177
cardiovascular diseases, neurological disorders, and acquired autoim-
delivery systems (Pandit et al., 2022).
6.2 GENE DELIVERY
mediated gene silencing. RNAi is a phenomenon that happens in nature
the gene (Gaul et al., 2018). About 20–25 nucleotide duplex RNAs called
expression. By attaching to miRNA recognition sites in the 30 untranslated